Publications by authors named "Patsy G Oliver"

Claim this Profile
S
STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer.
Megan E Conway, Joy M McDaniel, James M Graham, Katrin P Guillen, Patsy G Oliver

Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression.
Sumit Agarwal, Balabhadrapatruni V S K Chakravarthi, Hyung-Gyoon Kim, Nirzari Gupta, Kevin Hale, Patsy G Oliver

Transl Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Biomimetic Microphysiological Systems for Tissue Regeneration and Disease Modeling.
Karim I Budhwani, Patsy G Oliver, Donald J Buchsbaum, Vinoy Thomas

Adv Exp Med Biol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
Kelly M Kreitzburg, Samuel C Fehling, Charles N Landen, Tracy L Gamblin, Rebecca B Vance, Patsy G Oliver

Cancer Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction notice to "SRI36160 is a specific inhibitor of Wnt/-catenin signaling in human pancreatic and colorectal cancer cells" [Canc. Lett. 389C (2017) 41-48].
Yonghe Li, Patsy G Oliver, Wenyan Lu, Vibha Pathak, Sivaram Sridharan

Cancer Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models.
Benjamin B Kasten, Patsy G Oliver, Harrison Kim, Jinda Fan, Soldano Ferrone

Int J Mol Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.
Asmi Chakraborty, Kaitlyn A Dorsett, Hoa Q Trummell, Eddy S Yang, Patsy G Oliver

J Biol Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction of "Design and Synthesis of Novel Cyclic Amine Benzimidazoles for the Treatment of Pancreatic Cancer".
Vibha Pathak, Corinne E Augelli-Szafran, Han-Xun Wei, Yonghe Li, Patsy G Oliver

J Med Chem· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.
Yonghe Li, Patsy G Oliver, Wenyan Lu, Vibha Pathak, Sivaram Sridharan

Cancer Lett· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic regulation of invasion by STAT3 in triple negative breast cancer.
Joy M McDaniel, Katherine E Varley, Jason Gertz, Daniel S Savic, Brian S Roberts, Patsy G Oliver

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4.
Marie K Kirby, Ryne C Ramaker, Jason Gertz, Nicholas S Davis, Bobbi E Johnston, Patsy G Oliver

Mol Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels.
M Ryan Smith, Praveen K Vayalil, Fen Zhou, Gloria A Benavides, Reena R Beggs, Patsy G Oliver

Redox Biol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
Matthew J Schultz, Andrew T Holdbrooks, Asmi Chakraborty, William E Grizzle, Charles N Landen, Patsy G Oliver

Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel class of mitochondria-targeted soft electrophiles modifies mitochondrial proteins and inhibits mitochondrial metabolism in breast cancer cells through redox mechanisms.
Praveen K Vayalil, Joo-Yeun Oh, Fen Zhou, Anne R Diers, M Ryan Smith, Patsy G Oliver

PLoS One· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent read-through fusion transcripts in breast cancer.
Katherine E Varley, Jason Gertz, Brian S Roberts, Nicholas S Davis, Kevin M Bowling, Patsy G Oliver

Breast Cancer Res Treat· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
Patsy G Oliver, Albert F LoBuglio, Tong Zhou, Andres Forero, Hyunki Kim

Breast Cancer Res Treat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity.
Angelina I Londoño-Joshi, Patsy G Oliver, Yufeng Li, Choo Hyung Lee, Andres Forero-Torres

Breast Cancer Res Treat· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined modality therapy with TRAIL or agonistic death receptor antibodies.
Hope M Amm, Patsy G Oliver, Choo Hyung Lee, Yufeng Li, Donald J Buchsbaum

Cancer Biol Ther· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
Peter J Frederick, James E Kendrick, J Michael Straughn, Debbie L Della Manna, Patsy G Oliver

Int J Gynecol Cancer· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5.
John B Fiveash, G Yancey Gillespie, Patsy G Oliver, Tong Zhou, Michael L Belenky

Int J Radiat Oncol Biol Phys· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
Patsy G Oliver, Albert F LoBuglio, Kurt R Zinn, Hyunki Kim, Li Nan

Clin Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor activity of the TRA-8 anti-DR5 antibody in combination with cisplatin in an ex vivo human cervical cancer model.
James E Kendrick, J Michael Straughn, Patsy G Oliver, Wenquan Wang, Li Nan

Gynecol Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth.
Leo Christopher Derosier, Selwyn M Vickers, Kurt R Zinn, Zhi Huang, Wenquan Wang, Patsy G Oliver

Mol Cancer Ther· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer.
Leo Christopher DeRosier, Donald J Buchsbaum, Patsy G Oliver, Zhi-Qiang Huang, Jeffrey C Sellers

Clin Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model.
Jacob M Estes, Patsy G Oliver, J Michael Straughn, Tong Zhou, Wenquan Wang

Gynecol Oncol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis